Reversal of Multidrug Resistance in an Epirubicin-Resistant Gastric Cancer Cell Subline

BACKGROUND: Gastric cancer is one of the most common malignancies worldwide. Epirubicin (EPI) is used extensively in the treatment of multiple cancers despite its tendency to induce multidrug resistance though overexpression of the ABCB1 efflux pump. However, this overexpression can be disrupted usi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Asian Pac J Cancer Prev
Autors principals: Felipe, Aledson Vitor, de Oliveira, Juliana, Moraes, Andrea Aparecida, de França, Jerônimo Pereira, da Silva, Tiago Donizetti, Forones, Nora Manoukian
Format: Artigo
Idioma:Inglês
Publicat: West Asia Organization for Cancer Prevention 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6031827/
https://ncbi.nlm.nih.gov/pubmed/29801407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2018.19.5.1237
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars